Market Size by Technology (Chromatography {Liquid Chromatography, Gas Chromatography}, Spectroscopy), by Test (Potency Testing, Pesticide Screening, Heavy Metal Testing, Terpene Testing, Mycotoxin Testing) & Forecast.
Report ID: GMI3567
|
Published Date: March 2023
|
Report Format: PDF
Download Free PDF
Cannabis Testing Market Size
Cannabis Testing Market size was valued at more than USD 7 billion in 2022 and is set to record lucrative growth at over 13.5% CAGR through 2032 attributed to the growing legalization of cannabis in several countries for medical purposes.
As marijuana usage becomes more recognized and legal in the United States, the Netherlands, South Africa, and other parts of the world, there is a rising demand for precise and reliable analysis of cannabis products. While several governments have approved the recreational use of cannabis, the number of cannabis testing facilities has increased. Moreover, several government institutions and business players are realizing the commercial and social significance of authorized medicinal cannabis, which is projected to boost market growth.
Lack of uniform quality standards to slow down cannabis testing market landscape
Administering a precise dosage of cannabis for medical uses necessitates strict regulatory and quality control standards. Moreover, quality requirements in different nations are not consistent. For instance, distinct state laws and variances govern cannabis for both medicinal and adult usage in the United States. Different techniques used by various approved laboratories might result in discrepant findings and incorrect information about the cannabinoid content of cannabis. However, government authorities are taking efforts to increase market integrity and consumer access to correct information, which is likely to positively influence the industry trends.
Cannabis Testing Market Analysis
Cannabis testing market from chromatography segment is expected to generate a valuation of around USD 17.5 billion by 2032. Chromatographic methods are gaining prominence for cannabis testing as they provide quick and accurate results. Furthermore, reputed laboratories are investing in new technologies to enhance their service offering, which is likely to propel segment development. Additionally, its automation and configurability allow Smithers to analyze the most recent advancements in cannabis and terpenes methodologies and provide customers with a route toward strain phenotyping.
Pesticide screening segment held over 18.5% revenue share of the cannabis testing market in 2022 and is projected to dominate the industry through 2032. Due to the substantial health risks that pesticides provide to users, several jurisdictions, allow the use of certain pesticides under strict limits, while some have completely outlawed the use of pesticides on cannabis plants and mandate the testing of all cannabis products to guarantee that they are pesticide-free. Due to its selectivity, sensitivity, and toughness, LC-MS has emerged as a preferred technology for pesticide analysis. With the rapid expansion of the cannabis industry, the need for pesticide screening is expected to drive segment size.
Europe cannabis testing market held a sizable revenue share in 2022 and is estimated to grow at more than 14% CAGR over 2023-2032. The possession of small amounts of cannabis is no longer regarded as illegal in several European nations. Key businesses are developing cutting-edge technologies and cannabinoid products to explore new opportunities, which is expected to boost the regional market progression. U.S. cannabis testing industry is expected to grow at a CAGR of over 10.5% in the coming years owing to rigorous R&D initiatives to utilize cannabis for treating infections and illnesses.
Cannabis Testing Market Share
Green Scientific Labs
EVIO
Anandia Labs
Eurofins Scientific
Anresco
Eirlab
Digipath
SC Labs
Pure Analytics
PSI Labs LLC
Steep Hill
and Phytovista Laboratories
are some of the major companies operating in the market. To strengthen their market share, these firms are often involved in strategic projects including partnerships and service portfolio expansions.
Impact of COVID-19 Pandemic
The demand for cannabis-testing products with therapeutic benefits surged as people became increasingly concerned with their health and well-being after the onset of the COVID-19 pandemic. Given that cannabis extracts have an impact on the production of ACE2 and TMPRSS2 protein in human cells, researchers were looking into a variety of therapeutic possibilities, including cannabis. Hence, R&D initiatives to find various efficient cannabis applications to combat the COVID-19 infection benefitted market revenue.
The cannabis testing market research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD Million from 2018 to 2032 for the following segments:
By Technology
Chromatography
Liquid Chromatography
Gas Chromatography
Other
Spectroscopy
Mass Spectrometry
Atomic Spectroscopy
Others
By Test
Potency Testing
Pesticide Screening
Residual Solvent Screening
Heavy Metal Testing
Terpene Testing
Mycotoxin Testing
Others
The above information is provided for the following regions and countries:
North America
U.S.
Canada
Europe
Germany
Italy
France
Spain
UK
Belgium
Czech Republic
Denmark
Finland
Greece
Ireland
Norway
Poland
The Netherlands
Latin America
Argentina
Brazil
Chile
Colombia
Mexico
Rest of World
Australia
Thailand
Israel
Authors: Mariam Faizullabhoy, Gauri Wani
Cannabis Testing Market Scope
Cannabis Testing Market Size
Cannabis Testing Market Trends
Cannabis Testing Market Analysis
Cannabis Testing Market Share
Report Content
Chapter 1 Methodology & Scope
1.1 Market scope and definition
1.2 Base estimates and calculations
1.3 Forecast calculations
1.4 COVID-19 Impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Cannabis testing industry 3600 synopsis, 2018 - 2032
2.1.1 Business trends
2.1.2 Technology trends
2.1.3 Test type trends
2.1.4 Regional trends
Chapter 3 Cannabis Testing Industry Insights
3.1 Industry segmentation
3.2 Industry landscape
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing demand for cannabis legalization in several countries for medical purposes
3.3.1.2 Increasing research on various medical use of cannabis
3.3.1.3 Growing number of cannabis testing laboratories in various emerging markets
3.3.2 Industry pitfalls & challenges
3.3.2.1 Lack of uniformity in quality standards
3.3.2.2 High cost of laboratory equipment
3.4 Growth potential analysis
3.4.1 By technology
3.4.2 By test type
3.5 COVID-19 impact analysis
3.6 Regulatory scenario
3.6.1 U.S.
3.6.2 Canada
3.6.3 Europe
3.7 Cannabis testing lab application process, by region, 2021
3.7.1 North America
3.7.2 Europe
3.7.3 Latin America
3.8 Pricing analysis, by test type, 2022
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategic outlook matrix
4.6 Strategic dashboard
Chapter 5 Cannabis Testing Market, By Technology
5.1 Key technology trends
5.2 Chromatography
5.2.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.2.2 Liquid chromatography
5.2.2.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.2.3 Gas chromatography
5.2.3.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.2.4 Others
5.2.4.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.3 Spectroscopy
5.3.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.3.2 Mass spectrometry
5.3.2.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.3.3 Atomic spectroscopy
5.3.3.1 Market estimates and forecast, 2018 – 2032 (USD Million)
5.4 Others
5.4.1 Market estimates and forecast, 2018 – 2032 (USD Million)
Chapter 6 Cannabis Testing Market, By Test Type
6.1 Key test type trends
6.2 Potency testing
6.2.1 Market estimates and forecast, 2018 – 2032 (USD Million)
6.3 Pesticide screening
6.3.1 Market estimates and forecast, 2018 – 2032 (USD Million)
6.4 Residual solvent screening
6.4.1 Market estimates and forecast, 2018 – 2032 (USD Million)
6.5 Heavy metal testing
6.5.1 Market estimates and forecast, 2018 – 2032 (USD Million)
6.6 Terpene testing
6.6.1 Market estimates and forecast, 2018 – 2032 (USD Million)
6.7 Mycotoxin testing
6.7.1 Market estimates and forecast, 2018 – 2032 (USD Million)
6.8 Others
6.8.1 Market estimates and forecast, 2018 – 2032 (USD Million)
Chapter 7 Cannabis Testing Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 Italy
7.3.3 France
7.3.4 Spain
7.3.5 UK
7.3.6 Belgium
7.3.7 Czech Republic
7.3.8 Denmark
7.3.9 Finland
7.3.10 Greece
7.3.11 Ireland
7.3.12 Norway
7.3.13 Poland
7.3.14 The Netherlands
7.4 Latin America
7.4.1 Argentina
7.4.2 Brazil
7.4.3 Chile
7.4.4 Colombia
7.4.5 Mexico
7.5 Rest of World
7.5.1 Australia
7.5.2 Thailand
7.5.3 Israel
Chapter 8 Company Profiles
8.1 Anandia Labs
8.2 Anresco
8.3 Digipath
8.4 Eirlab
8.5 EVIO
8.6 Phytovista Laboratories
8.7 Pure Analytics
8.8 SC Labs
8.9 PSI Labs LLC
8.10 Green Scientific Labs
8.11 Eurofins Scientific
8.12 Steep Hill
Don't see your key competitors?
The companies listed in this report are a curated selection - not the full competitive universe.
Our market revenue calculations use a bottom-up methodology that accounts for all players across all regions - including manufacturers, distributors, and specialists not individually profiled. The profiles section spotlights strategically significant players; it does not define the scope of our market sizing.
Your competitive landscape may also include
Regional or domestic-only leaders not in the global top tier
Distributors and channel partners who control market access
Emerging disruptors, startups, or adjacent-industry entrants
Niche players focused on a specific application or end-use
Free customization - up to 20% of report value
Need specific data? Request customization and get the insights tailored to your exact requirements.
Authors: Mariam Faizullabhoy, Gauri Wani
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at[email protected]
Explore Our Licensing Options:
Premium Report Details
Base Year: 2022
Companies covered: 12
Tables & Figures: 289
Countries covered: 24
Pages: 250
Download Free PDF
Premium Report Details
Base Year: 2022
Companies covered: 12
Tables & Figures: 289
Countries covered: 24
Pages: 250
Download Free PDF
Share Content
Add Citations
Mariam Faizullabhoy. 2023, March. Cannabis Testing Market - by Technology (Chromatography {Liquid Chromatography, Gas Chromatography}, Spectroscopy), By Test (Potency Testing, Pesticide Screening, Heavy Metal Testing, Terpene Testing, Mycotoxin Testing) & Forecast, 2023-2032 (Report ID: GMI3567). Global Market Insights Inc. Retrieved May 4, 2026, from https://www.gminsights.com/toc/details/cannabis-testing-market
Cannabis Testing Market
Get a free sample of this report
Get a free sample of this report Cannabis Testing Market
Is your requirement urgent? Please give us your business email for a speedy delivery!
Cannabis Testing Market Size
Cannabis Testing Market size was valued at more than USD 7 billion in 2022 and is set to record lucrative growth at over 13.5% CAGR through 2032 attributed to the growing legalization of cannabis in several countries for medical purposes.
As marijuana usage becomes more recognized and legal in the United States, the Netherlands, South Africa, and other parts of the world, there is a rising demand for precise and reliable analysis of cannabis products. While several governments have approved the recreational use of cannabis, the number of cannabis testing facilities has increased. Moreover, several government institutions and business players are realizing the commercial and social significance of authorized medicinal cannabis, which is projected to boost market growth.
Lack of uniform quality standards to slow down cannabis testing market landscape
Administering a precise dosage of cannabis for medical uses necessitates strict regulatory and quality control standards. Moreover, quality requirements in different nations are not consistent. For instance, distinct state laws and variances govern cannabis for both medicinal and adult usage in the United States. Different techniques used by various approved laboratories might result in discrepant findings and incorrect information about the cannabinoid content of cannabis. However, government authorities are taking efforts to increase market integrity and consumer access to correct information, which is likely to positively influence the industry trends.
Cannabis Testing Market Analysis
Cannabis testing market from chromatography segment is expected to generate a valuation of around USD 17.5 billion by 2032. Chromatographic methods are gaining prominence for cannabis testing as they provide quick and accurate results. Furthermore, reputed laboratories are investing in new technologies to enhance their service offering, which is likely to propel segment development. Additionally, its automation and configurability allow Smithers to analyze the most recent advancements in cannabis and terpenes methodologies and provide customers with a route toward strain phenotyping.
Pesticide screening segment held over 18.5% revenue share of the cannabis testing market in 2022 and is projected to dominate the industry through 2032. Due to the substantial health risks that pesticides provide to users, several jurisdictions, allow the use of certain pesticides under strict limits, while some have completely outlawed the use of pesticides on cannabis plants and mandate the testing of all cannabis products to guarantee that they are pesticide-free. Due to its selectivity, sensitivity, and toughness, LC-MS has emerged as a preferred technology for pesticide analysis. With the rapid expansion of the cannabis industry, the need for pesticide screening is expected to drive segment size.
Europe cannabis testing market held a sizable revenue share in 2022 and is estimated to grow at more than 14% CAGR over 2023-2032. The possession of small amounts of cannabis is no longer regarded as illegal in several European nations. Key businesses are developing cutting-edge technologies and cannabinoid products to explore new opportunities, which is expected to boost the regional market progression. U.S. cannabis testing industry is expected to grow at a CAGR of over 10.5% in the coming years owing to rigorous R&D initiatives to utilize cannabis for treating infections and illnesses.
Cannabis Testing Market Share
are some of the major companies operating in the market. To strengthen their market share, these firms are often involved in strategic projects including partnerships and service portfolio expansions.
Impact of COVID-19 Pandemic
The demand for cannabis-testing products with therapeutic benefits surged as people became increasingly concerned with their health and well-being after the onset of the COVID-19 pandemic. Given that cannabis extracts have an impact on the production of ACE2 and TMPRSS2 protein in human cells, researchers were looking into a variety of therapeutic possibilities, including cannabis. Hence, R&D initiatives to find various efficient cannabis applications to combat the COVID-19 infection benefitted market revenue.
The cannabis testing market research report includes in-depth coverage of the industry with estimates & forecasts in terms of revenue in USD Million from 2018 to 2032 for the following segments:
By Technology
By Test
The above information is provided for the following regions and countries: